Logistics Protects: Bringing More Control to Temperature-Sensitive Logistics

By 2016, world sales of cold-chain drugs and biologics such as vaccines and blood plasma products will near $240bn. The increase has led to a surge in discussion about how to protect these products throughout the transportation logistics cycle.


Industry experts are recommending that the term "cold chain" be eliminated from rules, guidance and best-practice documents. "Cold chain" now includes a broader spectrum of temperature ranges, such as controlled room temperature (CRT).

Please download this free white paper for more information.

More About This Company